Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Vision science and adaptive optics, the state of the field

  • Marcos, Susana
  • Werner, John S.
  • Burns, Stephen A.
  • Merigan, William H.
  • Artal, Pablo
  • Atchison, David A.
  • Sincich, Lawrence C.
Susana Marcos et al. -- 31 pags., 13 figs., Adaptive optics is a relatively new field, yet it is spreading rapidly and allows new questions to be asked about how the visual system is organized. The editors of this feature issue have posed a series of question to scientists involved in using adaptive optics in vision science. The questions are focused on three main areas. In the first we investigate the use of adaptive optics for psychophysical measurements of visual system function and for improving the optics of the eye. In the second, we look at the applications and impact of adaptive optics on retinal imaging and its promise for basic and applied research. In the third, we explore how adaptive optics is being used to improve our understanding of the neurophysiology of the visual system., John S. Werner: NIH Grants R01 EY 024239, AG04058, P-30 EY012576 and Research to Prevent Blindness. Susana Marcos: European Research Council under the European Union’s Seventh Framework Program (FP/2007–2013)/ERC Grant Agreement [ERC- 2011-AdC 294099]. Spanish Government Grants FIS2011-25637 & FIS2014-56643-R, Spanish Government FPU and FPI Predoctoral Fellowships, CSIC JAE-Pre program., Pablo Artal: European Research Council Advanced Grant ERC-2013-AdG-339228 (SEECAT) and the Spanish SEIDI, grant FIS2013-41237-R. David Atchison: Australian Research Council Discovery Grants DP110102018 and DP140101480. Karen Hampson: UK College of Optometrists; EPSRC (Engineering and Physical Sciences Research Council), Grants EP/ D036550/1and EP/G015473/1. Linda Lundstrom: Swedish Agency for Innovation Systems (VINNMER 2008–00992) and Swedish Research Council (621-2011-4094). Geungyoung Yoon: NIH/NEI, NYSTAR. Stephen Burns and Ann Elsner NIH Grants EY007624, EY026105, EY024315 and EY004395. P30EY019008 and Foundation Fighting Blindness., Joseph Carroll: NIH R01EY017607, Foundation Fighting Blindness, and Research to Prevent Blindness. Stacey S. Choi and Nathan Doble: support by NIH EY020901 and Department of Defense (DoD) Telemedicine and Advanced Technology Research Center (TATRC) grant W81XWH-10-1-0738. Alfredo Dubra: the Burroughs Wellcome Fund, Research to Prevent Blindness, Glaucoma Research Foundation and National Eye Institute. Ravi Jonnal NEI K99 EY 026068. Donald Miller NEI R01-EY018339 and P30-EY019008. Michel Paques: Institut National de la Santé et de la Recherche Médicale (Contrat d’Interface 2011) the Agence Nationale de la Recherche (ANR-09-TECS-009, ANR-12-TECS-0015- 03 and LabEx LifeSenses ANR-10-LABX-65). Hannah Smithson and Laura K. Young: the John Fell Fund (University of Oxford), Fight for Sight, and the Wellcome Trust Institutional Strategic Support Fund. Yuhua Zhang: NIH Grants EY021903, EY024378, P30 EY003039) and NSF IIA-1539034., Melanie Campbell: Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada Collaborative Health Research Program. Jennifer Hunter: NIH R44 AG043645, R01 EY022371, R01 EY004367, P30 EY001319, and BRP-EY014375. Also supported by an unrestricted grant to the University of Rochester Department of Ophthalmology from Research to Prevent Blindness, New York, New York. Andrew Metha: Supported by an Australia Research Council (ARC) Discovery Project Grant (DP0984649), an ARC Discovery Early Career Researcher Award (DE120101931), an A.E. Rowden White Foundation benevolent bequest, and the University of Melbourne Interdis- ciplinary Seed Fund. Grazyna Palczewska: NIH NEI R44 AG043645, European Private Foundation. Jesse Schallek: NIH Grants EY023496-01, EY014375, EY001319, The Schmitt Program on Integrative Brain Research, the Research to Prevent Blindness Stein Innovation award, Research to Prevent Blindness Career Development award (Schallek), an unrestricted grant to the University of Rochester Department of Ophthalmology from Research to Prevent Blindness, New York, New York, and Canon Inc. Lawrence Sincich: National Eye Institute, Eyesight Foundation of Alabama.William H. Merigan: NIH R44 AG043645, R01 EY021166, and P30 EY001319. Also by an unrestricted grant to the University of Rochester Department of Ophthalmology from Research to Prevent Blindness, New York, New York., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Simulating Outcomes of Cataract Surgery: Important Advances in Ophthalmology

  • Marcos, Susana
  • Martínez-Enríquez, Eduardo
  • Viñas, María
  • Castro, Alberto de
  • Dorronsoro, Carlos
  • Bang, Seung Pil
  • Yoon, Geunyoung
  • Artal, Pablo
32 pags., 10 figs., As the human eye ages, the crystalline lens stiffens (presbyopia) and opacifies (cataract), requiring its replacement with an artificial lens [intraocular lens (IOL)]. Cataract surgery is the most frequently performed surgical procedure in the world. The increase in IOL designs has not been paralleled in practice by a sophistication in IOL selection methods, which rely on limited anatomical measurements of the eye and the surgeon's interpretation of the patient's needs and expectations. We propose that the future of IOL selection will be guided by 3D quantitative imaging of the crystalline lens to map lens opacities, anticipate IOL position, and develop fully customized eye models for ray-tracing-based IOL selection. Conversely, visual simulators (in which IOL designs are programmed in active elements) allow patients to experience prospective vision before surgery and to make more informed decisions about which IOL to choose. Quantitative imaging and optical and visual simulations of postsurgery outcomes will allow optimal treatments to be selected for a patient undergoing modern cataract surgery., The authors have received funding from the following sources: H2020-MSCA-ITN-2015- 675137 IMCUSTOMEYE (S.M.); ERC-2011-AdG-294099 PRESBYOPIA (S.M.); ERC-PoCOCT4IOL (S.M.); ERC-PoC-SimVisSim (S.M.); ERC-2018-AdG-833106-SilkEye (S.M.) and ERC-2013-AdG-339228 SEECAT (P.A.); Spanish Agencia Estatal de Investigación FIS2017- 84753-R (S.M.) and PID2019-105684RB-I00 (P.A.); Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia 19897/GERM/15 (P.A.); National Institutes of Health/National Eye Institute (G.Y.); Research to Prevent Blindness (G.Y.); and NYSTAR/CEIS/CoE (G.Y.).